Video Module

Emerging Insights on Adverse Events During ART and Implications for Treatment

In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data when selecting or modifying individualized ART regimens for patients with HIV infection.

Joseph J. Eron, Jr., MD

Darcy Wooten, MD

Video Module

Multimedia

Emerging Insights on Adverse Events During ART and Implications for Treatment

View Multimedia

Watch this dynamic faculty discussion on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD

Darcy Wooten, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 11, 2021 Expired: May 10, 2022

Introduction

INSTIs and Metabolic Toxicity

NRTIs and Metabolic Toxicity

Switching ART for Tolerability

Switching ART for Comorbidities

Slideset

Slides on Emerging Insights on Adverse Events During ART and Implications for Treatment

View Slideset

Gain expert insight on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD

Darcy Wooten, MD Released: May 11, 2021

Emerging Insights on Adverse Events During ART and Implications for Treatment

Emerging Insights on Adverse Events During ART and Implications for Treatment

Slides on Emerging Insights on Adverse Events During ART and Implications for Treatment

Leaving the CCO site